Home
Sarepta Therapeutics SRPT paid Tarplin, Downs & Young $90K for lobbying in Q2 2026 · Budget, Health Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $90,000
- Quarter
- Q2 2026
- Client
- Sarepta Therapeutics
- Reported
- 26/07/20
Up 0.0% from last quarter
What else happened in Sarepta Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Sarepta Therapeutics's other lobbying reports
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$90K
$90K
Reported 04/20
for Q1